Inicio › Trastorno depresivo mayor › Illinois
Ensayos clínicos de Trastorno depresivo mayor en Illinois
20 estudios sobre Trastorno depresivo mayor buscan participantes en Illinois.
Ciudades en Illinois
Texto oficial del estudio (inglés)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Charter Research - Chicago, Chicago
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 1 oct 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Chicago Research Center, Chicago
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 1 oct 2026 · NCT07573176Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Northwestern University, Chicago
- Baber Research Group, Naperville
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06559306A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Chicago Research Center, Chicago
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07621237A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Endeavor Health Evanston Hospital, Evanston
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07227454A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Rush University, Chicago
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06793397Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Chicago
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 sept 2026 · NCT07105111A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Advanced Quality Medical Research, Orland Park
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 8 sept 2026 · NCT07076407A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Chicago
- Draig Clinical Site, Skokie
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07610473Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Rush University Medical Center, Chicago
Reclutando
Edades de 22 a 70 · Todos los sexos · Actualizado el 28 ago 2026 · NCT06423430A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Uptown Research Institute, Chicago
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07592689A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- EmVenio Research, Chicago
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07115329Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Chicago
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 24 jul 2026 · NCT07484217A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
- Amr Conventions Research /ID# 277547, Warrenville
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 15 jun 2026 · NCT07276997Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Reclutando
Edades de 18 a 64 · Todos los sexos · Actualizado el 4 jun 2026 · NCT05051618A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Pillar Clinical Research LLC, Chicago
ReclutandoFase 2
Edades de 18 a 65 · Todos los sexos · Actualizado el 11 may 2026 · NCT06524830Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
ReclutandoEstudio observacional
Edades de 18 a 40 · Todos los sexos · Actualizado el 10 mar 2026 · NCT06740383Study of ALTO-300 in MDD
- Site 310, Chicago
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 jul 2025 · NCT05922878A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Chicago
ReclutandoFase 4
Edades de 18 a 65 · Todos los sexos · Actualizado el 23 ene 2025 · NCT06223880De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.